A carregar...

HIV-1 prophylactic vaccines: state of the art

The quest for an effective HIV-1 vaccine began early in the course of the HIV pandemic. Over time, the paradigm has evolved from B cell- towards T cell-based vaccines. Results from initial Phase II/III trials have been disappointing; however, while modest, the unexpected results of the Phase II/III...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virus Erad
Main Authors: Lelièvre, Jean-Daniel, Lévy, Yves
Formato: Artigo
Idioma:Inglês
Publicado em: Mediscript Ltd 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946697/
https://ncbi.nlm.nih.gov/pubmed/27482428
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!